Clinical Trial Update: Inhaled Morphine Compared With Morphine By Mouth in Treating Cancer Patients With Breakthrough Pain [Phase 2]

View source ↗

Summary

A Phase 2 study comparing inhaled morphine to oral morphine for breakthrough pain in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Inhaled morphine (morphine)
• Oral morphine (morphine)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Pain, Unspecified Adult Solid Tumor, Protocol Specific | Phase 2 | Status: COMPLETED